Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-60,499
Closed -$889K 177
2025
Q3
$889K Buy
60,499
+7,750
+15% +$79K 0.27% 73
2025
Q2
$518K Buy
52,749
+3,870
+8% +$32K 0.17% 108
2025
Q1
$355K Buy
48,879
+9,440
+24% +$82.5K 0.13% 125
2024
Q4
$308K Sell
39,439
-6,720
-15% -$55.3K 0.1% 137
2024
Q3
$342K Buy
46,159
+13,783
+43% +$116K 0.11% 137
2024
Q2
$259K Sell
32,376
-550
-2% -$4.91K 0.09% 146
2024
Q1
$383K Buy
32,926
+13,926
+73% +$154K 0.13% 126
2023
Q4
$212K Buy
+19,000
New +$175K 0.09% 154

Other funds holding ETNB

Gilliland Jeter Wealth Management's ETNB Position: Q4 2025 in Review

Gilliland Jeter Wealth Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 60,499 shares — an estimated $889K sold.

Gilliland Jeter Wealth Management first reported a position in ETNB in Q4 2023 and held it in 8 quarters. The position peaked at $889K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Gilliland Jeter Wealth Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Gilliland Jeter Wealth Management sold 60,499 89bio shares in Q4 2025, an estimated $889K.
  • Gilliland Jeter Wealth Management first reported a position in 89bio in Q4 2023 and held it in 8 quarters.
  • Gilliland Jeter Wealth Management's 89bio position peaked at $889K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Gilliland Jeter Wealth Management's 13F filing for Q4 2025, filed 23 Jan 2026.